Preferences and perceptions of patients with metastatic castration-resistant prostate cancer for treatments and biomarker testing: An international qualitative study. This is an ASCO Meeting Abstract ...

We’re just starting to tap the potential of what AI can do. But amid all the breakthroughs, one thing is fundamental: AI is only as good as the data it was trained on. Unlike people, who can draw on ...

The use of analytics is no longer limited to big companies with deep pockets. It’s now widespread, with 59% of enterprises using analytics in some capacity. And companies are capitalizing on this ...